Results 31 to 40 of about 20,732 (116)

Calcitonin-Secreting Neuroendocrine Carcinoma of Larynx with Metastasis to Thyroid

Case Reports in Endocrinology, 2015
Primary neuroendocrine tumors of the larynx are rare, with moderately differentiated neuroendocrine carcinoma (MDNC) being the most frequent histologic type. We report a MDNC in a 57-year-old gentleman with an enlarging right-sided neck mass.
Lauren LaBryer, Ravindranauth Sawh, Colby McLaurin, R. Hal Scofield   +3 more
doaj   +1 more source

A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors

Therapeutic Advances in Medical Oncology, 2023
Background: Gastroenteropancreatic (GEP) neuroendocrine neoplasms with Ki-67 > 20% were subdivided in the most recent 2019 World Health Organization histopathological classification into grade 3 (G3) neuroendocrine tumors (NETs), described as well ...
Mauro D. Donadio, Ângelo B. Brito, Rachel P. Riechelmann   +2 more
doaj   +1 more source

Chromophobe renal cell carcinoma of the kidney with neuroendocrine differentiation: A case report with review of literature

Urology Annals, 2015
Chromophobe renal cell carcinoma (chRCC) is a distinctive type of malignant kidney tumor characterized by large cells with defined cell membrane. Primary renal neuroendocrine tumors (NET) are rare with morphology similar to NET at other sites.
Ghadeer A Mokhtar, Reem Al-Zahrani
doaj   +1 more source

Clinicopathological study of 100 cases of neuroendocrine neoplasms of the gastroenteropancreatic system: A tertiary cancer center experience

Indian Journal of Medical and Paediatric Oncology, 2020
Background: The incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) is on the rise. Although the clinicopathologic characteristics of NENs have been previously reviewed in the literature, the data published in the Indian literature so
Satarupa Tarak Nath Samanta, Shailee Paresh Bhai Mehta, Trupti S Patel, Dhaval H Jetly   +3 more
doaj   +1 more source

Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute

Endocrine Oncology
Objective: Gastric neuroendocrine neoplasms (G-NENs) are rare tumors categorized into subtypes, each exhibiting unique characteristics, levels of aggressiveness and prognostic implications.
Sarah Adelaide M Campos, Bruno Vilhena Pereira, Cibele Barbosa Carroll, Rinaldo Gonçalves, Reinaldo Rondinelli, Daniel Bulzico   +5 more
doaj   +1 more source

Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2

Case Reports in Pathology, 2013
Testicular neuroendocrine tumors (NET) or carcinoid tumors are rare neoplasms which represent 1% of all testicular tumors and can be divided into 3 subgroups: pure primary testicular NET, primary testicular NET associated with a teratoma, and NET ...
Jonathan R. Epperson, Necia M. Pope, Margaret J. Abuzeid   +2 more
doaj   +1 more source

Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors

Journal of Hematology & Oncology, 2011
Pancreatic neuroendocrine tumors (NET) have diverse clinical presentations. Patients with symptoms of hormone secretion may require specific medical interventions to control those symptoms prior to antitumor intervention.
Picus Joel, Kvols Larry, Bendell Johanna, Kulke Matthew H, Pommier Rodney, Yao James   +5 more
doaj   +1 more source

A case of lipid-rich neuroendocrine tumor of the gallbladder mimicking a cholesterol polyp

Human Pathology: Case Reports, 2020
Neuroendocrine tumors (NETs) are rare in the gallbladder possibly because of paucity of the precursor neuroendocrine cells in this organ. Lipid-rich NET (LR-NET), also known as clear cell NET, is a rare but distinct variant of NET observed in various ...
Yasuji Yoshikawa, Takashi Masuda
doaj   +1 more source

Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms

BMC Cancer, 2020
Background Oncolytic virotherapy is an upcoming treatment option for many tumor entities. But so far, a first oncolytic virus only was approved for advanced stages of malignant melanomas.
Linus D. Kloker, Susanne Berchtold, Irina Smirnow, Julia Beil, Andreas Krieg, Bence Sipos, Ulrich M. Lauer   +6 more
doaj   +1 more source

Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors

Frontiers in Oncology, 2019
Biliary neuroendocrine neoplasms (NENs) represent <1% of all NENs. The aim of this retrospective study is to present the clinical characteristics, management and prognosis profiles of 28 biliary NEN patients from a large tertiary center, and identify ...
Zhibo Zheng, Chuyan Chen, Binglu Li, Hongbo Liu, Liangrui Zhou, Hui Zhang, Chaoji Zheng, Xiaodong He, Wei Liu, Tao Hong, Yupei Zhao   +10 more
doaj   +1 more source